指南与共识消化与肝胆胰病理

慢性炎症性肠病相关结直肠异型增生的当代共识分类及观察者间研究

Colorectal dysplasia in chronic inflammatory bowel disease: a contemporary consensus classification and interobserver study.
指南 / 共识 · Hum Pathol · 2023-05-27

该国际工作组针对慢性炎症性肠病(IBD)相关异型增生提出新分类系统,涵盖肠道型、胃型及混合型三大类共九个亚类,并通过随机选取的潜在癌前病变电子图像测试病例评估观察者间一致性。结果显示67%的诊断被认为确定,总体达到显著一致性;肠道与胃型病变区分一致性显著,锯齿状与非锯齿状区分一致性中等,但某些锯齿状亚类间仅一般一致性。基于Riddell分级,确定异型增生占集体反应的86%(低级别75%,高级别11%)。

要点

  • 新分类将IBD相关异型增生分为肠道型、胃型和混合型三大类共九个亚类。
  • 67%的诊断达确定,总体观察者间一致性显著;肠道与胃型区分一致性显著,锯齿状与非锯齿状区分中等。
  • 基于Riddell分级,确定异型增生占86%,其中低级别75%、高级别11%。

核心结论

  • 新分类系统涵盖三大类九个亚类,可为未来IBD临床与基础研究提供坚实基础。

研究设计与样本

  • 国际病理学家工作组制定新分类系统,并通过随机选取潜在癌前病变电子图像测试病例评估可重复性。

主要发现

  • 67%的诊断被认为确定,总体达到显著观察者间一致性。
  • 肠道与胃型病变区分总体一致性显著,锯齿状与非锯齿状病变区分总体一致性中等。
  • 某些锯齿状亚类间区分仅达到一般一致性。
  • 基于Riddell分级,确定异型增生占集体反应的86%(低级别75%,高级别11%)。

关键数值与推荐

  • 新分类包括肠道型异型增生(管状/绒毛状腺瘤样、杯状细胞缺失、隐窝细胞、传统锯齿状腺瘤样、无蒂锯齿状病变样及锯齿状NOS)、胃型异型增生(管状/绒毛状及锯齿状)和混合型肠-胃异型增生。

临床怎么用

  • 病理医生可依据新分类对IBD相关异型增生进行肠道型、胃型及混合型分类,并注意锯齿状亚类间一致性较低。

局限性

  • 某些锯齿状亚类间观察者间一致性仅一般。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The clinical management of patients with dysplasia in chronic inflammatory bowel disease (IBD) is currently guided by Riddell et al.'s grading system (negative, indefinite, low grade, high grade) from 1983 which was based primarily on nuclear cytoarchitectural characteristics. Although most dysplasia in IBD resembles sporadic adenomas morphologically, other distinctive potential cancer precursors in IBD have been described over time. Recognizing the need for a updated comprehensive classification for IBD-associated dysplasia, an international working group of pathologists with extensive clinical and research experience in IBD devised a new classification system and assessed its reproducibility by having each participant assess test cases selected randomly from a repository of electronic images of potential cancer precursor lesions. The new classification system now encompasses three broad categories and nine sub-categories: 1) intestinal dysplasia (tubular/villous adenoma-like, goblet cell deficient, crypt cell, traditional serrated adenoma-like, sessile serrated lesion-like and serrated NOS), 2) gastric dysplasia (tubular/villous and serrated), and 3) mixed intestinal-gastric dysplasia. In the interobserver analysis, 67% of the diagnoses were considered definitive and achieved substantial inter-rater agreement. The key distinctions between intestinal and gastric lesions and between serrated and non-serrated lesions achieved substantial and moderate inter-rater agreement overall, respectively, however, the distinctions among certain serrated sub-categories achieved only fair agreement. Based on the Riddell grading system, definite dysplasia accounted for 86% of the collective responses (75% low grade, 11% high grade). Based on these results, this new classification of dysplasia in IBD can provide a sound foundation for future clinical and basic IBD research.

来源:Hum Pathol,查看原文。版权归原作者所有。

引用

  1. Harpaz N, Goldblum JR, Shepherd NA, et al. Colorectal dysplasia in chronic inflammatory bowel disease: a contemporary consensus classification and interobserver study. Hum Pathol. 2023. PMID: 37247824. doi:10.1016/j.humpath.2023.05.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。